Your browser doesn't support javascript.
loading
Time course of induction of metabolism of all-trans-retinoic acid and the up-regulation of cellular retinoic acid-binding protein.
Adamson, P C; Boylan, J F; Balis, F M; Murphy, R F; Godwin, K A; Gudas, L J; Poplack, D G.
  • Adamson PC; Pediatric Branch, National Cancer Institute, Bethesda, Maryland 20892.
Cancer Res ; 53(3): 472-6, 1993 Feb 01.
Article en En | MEDLINE | ID: mdl-8381046
ABSTRACT
A study of chronic i.v. dosing of all-trans-retinoic acid (all-trans-RA) was performed to determine whether induction of the capacity-limited elimination process for all-trans-RA occurred with long-term drug administration. Because up-regulation of the cellular retinoic acid-binding proteins (CRABP) may act to bind all-trans-RA intracellularly, the amount of CRABP in skin biopsy samples obtained during and following the course of all-trans-RA administration was also determined. Four adult rhesus monkeys received 50 mg/m2 of all-trans-RA by bolus i.v. injection daily for 8 consecutive days and again for one additional dose following a 7-day period without drug. The plasma disappearance curve of all-trans-RA was characterized by a plateau phase, the duration of which decreased during the period of chronic drug administration, followed by a terminal exponential decay phase, which is consistent with a capacity-limited (saturable) elimination process. The Vmax of this process increased from 0.06 mumol/min on the first day to 0.17 mumol/min by the eighth day of all-trans-RA administration, consistent with induction of an enzymatic process. The amount of CRABP measured in skin biopsy specimens was rapidly induced, increasing to approximately 3-fold baseline levels by day 3 of all-trans-RA administration. It remained at this level throughout the period of chronic drug administration but diminished following the 7-day period without drug. These findings suggest that an intermittent schedule of administration for all-trans-RA has potential advantages over a continuous administration schedule. A period of time without drug administration would allow for return of plasma drug clearance toward baseline levels and down-regulation of CRABP, which could result in higher plasma drug concentrations and possibly less cytoplasmic binding of drug.
Asunto(s)
Search on Google
Banco de datos: MEDLINE Asunto principal: Tretinoina / Proteínas Portadoras / Regulación hacia Arriba Límite: Animals Idioma: En Año: 1993 Tipo del documento: Article
Search on Google
Banco de datos: MEDLINE Asunto principal: Tretinoina / Proteínas Portadoras / Regulación hacia Arriba Límite: Animals Idioma: En Año: 1993 Tipo del documento: Article